Ctic stock earnings
WebCTIC Stock Price - CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. ... The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the ... WebApr 3, 2024 · CTIC Complete CTI BioPharma Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Ctic stock earnings
Did you know?
WebStock Quote. Change Volume 52 Week High 52 Week Low Apr 13, 2024 1:41 PM EDT. Data Provided by Refinitiv. ... Wash. , April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today … WebStock Price Forecast. The 9 analysts offering 12-month price forecasts for CTI Biopharma Corp have a median target of 10.00, with a high estimate of 15.00 and a low estimate of …
WebAug 1, 2024 · Get the latest CTI BioPharma Corp. (CTIC) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. ... Financials Dividends Adv. Charts Earnings Options ... WebApr 9, 2024 · 6 brokers have issued 12 month price targets for CTI BioPharma's shares. Their CTIC share price forecasts range from $9.00 …
WebMar 28, 2024 · CTI BioPharma Corp. (CTIC) latest earnings report: revenue, EPS, surprise, history, news and analysis. WebApr 6, 2024 · The CTI BioPharma stock price gained 3.68% on the last trading day (Thursday, 6th Apr 2024), rising from $4.08 to $4.23. During the last trading day the stock fluctuated 7.99% from a day low at $4.01 to a day high of $4.33. The price has fallen in 5 of the last 10 days and is down by -1.63% for this period. Volume has increased on the last …
WebThe Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingSep 2024 , …
WebCTIC Stock Summary. CTI BIOPHARMA CORP's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 3.63% of US listed stocks. ... CTI BioPharma Corp. (NASDAQ:CTIC) Q4 2024 Earnings Call Transcript March 6, 2024 Operator: Good morning, and welcome to the CTI BioPharma Fourth Quarter and Year … sv termine märz 2022WebAug 1, 2024 · Get the latest CTI BioPharma Corp. (CTIC) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. ... Financials … sv testcaseWebStock is heavily short : 20% of float is short 80% Institutional investors. nice swing opportunity for a re-bounce to the upper "resistance" channel line. NASDAQ:CTIC Stock had decent drop right after earnings to the lowest channel support line. Stock is heavily short : 20% of float is short 80% Institutional investors. brandon vogt podcastWebMar 17, 2024 · CTI BioPharma Corp. analyst estimates, including CTIC earnings per share estimates and analyst recommendations. brandon viskovichWebApr 7, 2024 · CTI BioPharma Corp’s trailing 12-month revenue is $53.9 million with a -172.4% profit margin. Year-over-year quarterly sales growth most recently was %. … brandon vu rodriguezWebCTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended December 2024. ... CTIC Stock Quotes API . CTIC … sv teutonia überruhrWebMar 6, 2024 · The "days to cover" for this stock exceeds 18 days. ... Zacks Investment Research reports that the 2024 Price to Earnings ratio for CTIC is -7.47 vs. an industry … svtfoe kisscartoon